Price to Sales ratio Analysis of Harrow Health Inc. 8.625% NT - Deep Dive


Latest FY PS
Period Ending - Dec-23

6.20


Very Poor PS
Period Ending - Dec-22
8346.54

Very Poor PS
Growth
-99.93 %
Trailing Twelve Months PS
Period Ending - Dec-23

6.04


Very Poor PS
PS Analysis of Harrow Health Inc. 8.625% NT
P/S Ratio of Harrow Health Inc. 8.625% NT with value of 6.04 indicates that stock price is high compared to sales of the company and may be overvalued.
PS Ratio of HROWL drastically fell by -99.93 % this year.
PS Ratio with value of 13030.06 was highest in Year Dec-20 in last Five Years.
PS Ratio of HROWL trending down for at least three Years.
Latest PS Ratio with value of 6.20 is lower than Average PS of 8670.89 in last five years.
Other PS Related Info of HROWL that may interest you.
Harrow Health Inc. 8.625% NT Overview
CodePricePrevious PricePrice ChangeSector
HROWL24.729924.57 0.651 % MISC
Fundamental AnalysisTechnical Analysis
Defination of Price to Sales
The Price to Sales Ratio indicates how much investors are willing to pay for each rupee of sales generated by a company. Price-to-Sales Ratio is used to determine whether a stock is currently profitable or less profitable, which is helpful for better investment decisions.   more ..
Price to Sales Formula

PS Related Ratios
PriceToBookRatioPriceToEarningRatioAssetTurnoverRatio

Tsr Value Index
Poor Value Stock
FY - Historical Price to Sales of Harrow Health Inc. 8.625% NT
PeriodDec-23Dec-22Dec-21Dec-20Dec-19Dec-18Dec-17
PS6.208346.549179.6313030.0612792.0214233.5318498.67
Change-99.93 %-9.08 %-29.55 %1.86 %-10.13 %-23.06 %17.06 %
You are view first 7 Records. Log in to view all 17 in Premium view
FY Chart of Price to Sales of Harrow Health Inc. 8.625% NT


Note : All Data Generated at the End of Trading Hours (EOD Data)